Get all your news in one place.
100's of premium titles.
One app.
Start reading
Bangkok Post
Bangkok Post
Business

Innobic, Aztiq aim to take Thailand’s life sciences sector to the next level

Innobic (Asia) Co., Ltd., a wholly-owned subsidiary and life science arm of the national oil and gas conglomerate PTT, together with Aztiq HK Ltd., is acting on its promise to uplift Thailand’s life science business by completing a deal to buy out Alvogen Emerging Markets Holdings Ltd. (AEMH), raising Innobic’s shareholding in Taiwan-based Lotus Pharmaceutical Co., Ltd. to 37% from 6.6%.

The share purchase transaction, worth US$475 million, was officially celebrated at Four Seasons Bangkok Hotel on 9 May 2022, making Innobic a major shareholder in Lotus Pharmaceutical. AEMH was previously the major shareholder in Lotus Pharmaceutical.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.